Clinical Trials
7 trialsNCT01164202 2022-03-18
SATURNE
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
NCT00524316 2017-05-09
Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Roswell Park Cancer Institute
Phase 2 Terminated
NCT00361309 2014-03-18
SU011248 in Advanced Hepatocellular Carcinoma
Massachusetts General Hospital
Phase 2 Completed
NCT01215565 2014-03-13
Fibrolam
Assistance Publique - Hôpitaux de Paris
Phase 2 Terminated
NCT00514228 2012-06-26
Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Swiss Cancer Institute
Phase 2 Completed
NCT00495625 2012-03-27
Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
NCT00247676 2010-02-18
An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer
Pfizer
Phase 2 Completed